Upgrade to SI Premium - Free Trial

Leerink Partners Cuts Price Target on Amgen (AMGN); Reiterates Market Perform

October 28, 2016 7:05 AM
Leerink Partners maintained a Market Perform rating on Amgen (NASDAQ: AMGN), and cut the price target to $163.00 (from $193.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles